---
$id: https://graph.org.ai/products/commodity/51263116
$type: Product
source: UNSPSC
code: "51263116"
title: "Butofilolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butofilolol

**UNSPSC Code**: 51263116
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H26FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4AZC6Y5A8G, chemically known as 1-butanone, 1-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-fluorophenyl)- but generally known as butofilolol, which bears US NIH Compound Identifier 68838. Butofilolol most often comes in base and maleate forms. European Medicines Agency schedules Butofilolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06029MIG. The term BUTOFILOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). BUTOFILOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butofilolol under HS 29221980 and SITC 51461. As of Q4 2014, BUTOFILOLOL remains the US FDA Preferred Term for this commodity. Butofilolol bears US NLM identifiers UMLS ID C0054262 and NCI Concept Code C77940. SMILES: FC1CC(C(OCC(O)CNC(C)(C)C)CC1)C(=O)CCC.

